Diabetes, Vol 47, Issue 11 1735-1747, Copyright © 1998 by American Diabetes Association

ARTICLES

Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake

MF Nielsen, R Basu, S Wise, A Caumo, C Cobelli and RA Rizza
Department of Medicine, Aarhus Kommunehospital, Denmark.

The present studies were undertaken to determine whether people with type 2 diabetes are resistant to the effects of glucose as well as insulin. Diabetic and nondiabetic subjects were studied on three occasions. Hormone secretion was inhibited with somatostatin. Insulin concentrations were kept at "basal" levels (referred to as low insulin infusion) from 0 to 180 min then increased to approximately 200 pmol/l from 181 to 360 min (referred to as high insulin infusion). Glucose concentrations were clamped at either approximately 95, approximately 130, or approximately 165 mg/dl on each occasion. In the presence of basal insulin concentrations, a progressive increase in glucose from 95 to 130 to 165 mg/dl was accompanied by a comparable and progressive decrease (P = 0.001 to 0.003 by analysis of variance [ANOVA]) in endogenous glucose production (measured with [6-(3)H]glucose) and total glucose output (measured with [2-(3)H]glucose) and incorporation of 14CO2 into glucose (an index of gluconeogenesis) in both diabetic and nondiabetic subjects, indicating normal hepatic (and perhaps renal) response to glucose. In the nondiabetic subjects, an increase in glucose concentration from 95 to 130 to 165 mg/dl resulted in a progressive increase in glucose disappearance during both the low (19.9 +/- 1.8 to 23.6 +/- 1.8 to 25.4 +/- 1.6 micromol x kg(-1) x min(-1); P = 0.003 by ANOVA) and high (36.4 +/- 3.1 to 47.6 +/- 4.5 to 61.1 +/- 7.0 micromol x kg(-1) x min(-1); P = 0.001 by ANOVA) insulin infusions. In contrast, in the diabetic subjects, whereas an increase in glucose from 95 to 130 mg/dl resulted in an increase in glucose disappearance during both the low (P = 0.001) and high (P = 0.01) dose insulin infusions, a further increase in glucose concentration to 165 mg/dl had no further effect (P = 0.41 and 0.38) on disappearance at either insulin dose (low: 14.2 +/- 0.8 to 18.2 +/- 1.1 to 18.7 +/- 2.4 micromol x kg(-1) x min(-1); high: 21.0 +/- 3.2 to 33.9 +/- 6.4 to 32.5 +/- 8.0 micromol x kg(-1) x min(-1) for 95, 130, and 165 mg/dl, respectively). We conclude that whereas glucose-induced stimulation of its own uptake is abnormal in type 2 diabetes, glucose-induced suppression of endogenous glucose production and output is not. The abnormality in uptake occurs in the presence of both basal and high insulin concentrations and is evident at glucose concentrations above but not below 130 mg/dl, implying a defect in a glucose-responsive step.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. M. Breckenridge, B. A. Cooperberg, A. M. Arbelaez, B. W. Patterson, and P. E. Cryer Glucagon, in Concert With Insulin, Supports the Postabsorptive Plasma Glucose Concentration in Humans Diabetes, October 1, 2007; 56(10): 2442 - 2448. [Abstract] [Full Text] [PDF]

				G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis Diabetes, June 1, 2007; 56(6): 1703 - 1711. [Abstract] [Full Text] [PDF]

				R. Basu, V. Chandramouli, B. Dicke, B. Landau, and R. Rizza Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis Diabetes, July 1, 2005; 54(7): 1942 - 1948. [Abstract] [Full Text] [PDF]

				M. F. Nielsen, A. Caumo, N. K. Aagaard, V. Chandramouli, W. C. Schumann, B. R. Landau, O. Schmitz, and H. Vilstrup Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1135 - G1143. [Abstract] [Full Text] [PDF]

				M. Shiota, P. Galassetti, K. Igawa, D. W. Neal, and A. D. Cherrington Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1160 - E1167. [Abstract] [Full Text] [PDF]

				K. M. Krudys, M. G. Dodds, S. M. Nissen, and P. Vicini Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1038 - E1046. [Abstract] [Full Text] [PDF]

				A. Parvanova, I. Iliev, M. Filipponi, B. D. Dimitrov, M. Vedovato, A. Tiengo, R. Trevisan, G. Remuzzi, and P. Ruggenenti Insulin Resistance and Proliferative Retinopathy: A Cross-Sectional, Case-Control Study in 115 Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4371 - 4376. [Abstract] [Full Text] [PDF]

				R. C. Camacho, D. B. Lacy, F. D. James, R. H. Coker, and D. H. Wasserman Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E269 - E274. [Abstract] [Full Text] [PDF]

				R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]

				M. F. Nielsen, A. Caumo, V. Chandramouli, W. C. Schumann, C. Cobelli, B. R. Landau, H. Vilstrup, R. A. Rizza, and O. Schmitz Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E102 - E110. [Abstract] [Full Text]

				M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2748 - 2758. [Abstract] [Full Text] [PDF]

				J. Shearer, A. Farah, T. de Paulis, D. P. Bracy, R. R. Pencek, T. E. Graham, and D. H. Wasserman Quinides of Roasted Coffee Enhance Insulin Action in Conscious Rats J. Nutr., November 1, 2003; 133(11): 3529 - 3532. [Abstract] [Full Text] [PDF]

				A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E25 - E30. [Abstract] [Full Text] [PDF]

				P. E. Carey, J. Halliday, J. E. M. Snaar, P. G. Morris, and R. Taylor Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E688 - E694. [Abstract] [Full Text] [PDF]

				R. C. Andrews, O. Rooyackers, and B. R. Walker Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 285 - 291. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, K. Reddy, L. Rossetti, and H. Shamoon Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects Diabetes, July 1, 2002; 51(7): 2179 - 2189. [Abstract] [Full Text] [PDF]

				A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity Diabetes, June 1, 2001; 50(6): 1351 - 1362. [Abstract] [Full Text]

				A. Mari, G. Pacini, E. Murphy, B. Ludvik, and J. J. Nolan A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test Diabetes Care, March 1, 2001; 24(3): 539 - 548. [Abstract] [Full Text]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, F. W. Schwenk, J. J. Holst, and R. A. Rizza Effect of Glucagon-Like Peptide-1(7-36)-Amide on Initial Splanchnic Glucose Uptake and Insulin Action in Humans With Type 1 Diabetes Diabetes, March 1, 2001; 50(3): 565 - 572. [Abstract] [Full Text]

				R. Basu, A. Basu, M. Nielsen, P. Shah, and R. A. Rizza Effect of Overnight Restoration of Euglycemia on Glucose Effectiveness in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2314 - 2319. [Abstract] [Full Text]

				R. Hovorka, F. Shojaee-Moradie, P. V. Carroll, L. J. Chassin, I. J. Gowrie, N. C. Jackson, R. S. Tudor, A. M. Umpleby, and R. H. Jones Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E992 - E1007. [Abstract] [Full Text] [PDF]